Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor

Metabolism: Clinical and Experimental

Volumn 49, Issue 3, 2000, Pages 347-352

  Koyama, Motoi ^a,b   Wada, Ryuichi ^a,b   Mizukami, Hiroki ^a,b   Sakuraba, Hiroyasu ^a,b   Odaka, Hiroyuki ^a,b   Ikeda, Hitoshi ^a,b   Yagihashi, Soroku ^a,b  

^a HIROSAKI UNIVERSITY   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BROXURIDINE; VOGLIBOSE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DIABETOGENESIS; DRUG EFFICACY; DRUG MECHANISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0034060985     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90242-7     Document Type: Article

References (34)

1. De Fronzo RA, Ferrannini E: The pathogenesis of non-insulin-dependent diabetes. An update. Medicine 61:125-140, 1982
2. Weir GC: Non-insulin-dependent diabetes mellitus: Interplay between B-cell independency and insulin resistance. Am J Med 73:461-464, 1982
3. Unger RH, Grundy S: Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implication for the management of diabetes. Diabetologia 28:119-121, 1985
4. Stefan Y, Orci L, Malaisse-Lagae F, et al: Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31:694-700, 1992
5. Rahier J, Goebbels RM, Henquin JC: Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371, 1983
6. Goto Y, Kakizaki M, Masaki N: Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc Jpn Acad 51:80-85, 1975
7. Goto Y, Kakizaki M: The spontaneous diabetes rat: A model of noninsulin dependent diabetes mellitus. Proc Jpn Acad 57B:381-384, 1981
8. Goto Y, Suzuki K, Sasaki M, et al: GK rat as model of nonobese, noninsulin-dependent diabetes. Selective breeding over 35 generations, in Shafrir E, Renold AE (eds): Frontiers in Diabetes Research. Lessons From Animal Diabetes, vol 2. London, UK, Libbey, 1988, pp 301-303
9. Yagihashi S, Goto K, Kakizaki M, et al: Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 15:309-312, 1978
10. Suzuki K-I, Goto Y, Toyota T: Spontaneously diabetic GK (Goto-Kakizaki) rats, in Shafrir E (ed): Lessons From Animal Diabetes, vol 4. London, UK, Smith-Gordon, 1990, pp 107-116
11. Portha B, Serrades P, Bailbe D, et al: Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40:486-491, 1991
12. Ostensen CG, Khan A, Abdel-Halim SM, et al: Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 36:3-8, 1993
13. Giroix MH, Vesco L, Portha B: Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 132:815-822, 1993
14. Movassat J, Saulnier C, Portha B: Beta-cell mass depletion precedes the onset of hyperglycemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus. Diabete Metab 21:365-370, 1995
15. Movassat J, Saulnier C, Serradas P, et al: Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 40:916-925, 1997
16. Guenifi A, Abel-Halim SM, Hoog A, et al: Preserved beta-cell density in the endocrine pancreas of young, spontaneously diabetic Goto-Kakizaki (GK) rats. Pancreas 10:148-153, 1995
17. Ohneda M, Johnson JH, Inman LR, et al: GLUT2 expression and function in beta-cells of GK rats with NIDDM. Diabetes 42:1065-1072, 1993
18. Koyama M, Wada R, Sakuraba H, et al: Accelerated loss of islet β-cells in sucrose-fed GK rat, a genetic model for non-insulin-dependent diabetes. Am J Pathol 153:537-545, 1998
19. Klöppel G, Drenck CR, Oberholzer M, et al: Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 403:441-452, 1984
20. Zhu M, Noma Y, Mizuno A, et al: Poor capacity for proliferation of pancreatic β-cell in Otsuka-Long-Evans Tokushima fatty rat: A model of spontaneous NTDDM. Diabetes 45:941-946, 1996
21. Ostenson CG, Abdel-Halim SM, Andersson A, et al: Studies on the pathogenesis of NIDDM in the GK (Goto-Kakizaki) rat, in Shafrir E (ed): Lessons From Animal Diabetes, vol 6. Boston, MA, Birkhäuser, 1996, pp 299-315
22. Baetens D, Stefan Y, Ravazzola M, et al: Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27:1-7, 1978
23. Shino A, Matsuo T, Iwatsuka H, et al: Structural changes of pancreatic islets in genetically obese rats. Diabetologia 9:413-421, 1973
24. Odaka H, Sano Y, Yamada Y, et al: Comparison of the effects of Voglibose (AO-128) and acarbose on postprandial hyperglycemia and intestinal carbohydrate absorption in rats. Jpn Pharmacol Ther 22:3491-3500, 1994
25. Lebovitz HE: α-Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev 6:132-145, 1998
26. Noma Y, Bonner-Weir S, Latimer JB, et al: Translocation of glucokinase in pancreatic beta-cells during acute and chronic hyperglycemia. Endocrinology 137:1485-1491, 1996
27. Roche E, Assimacopoulos-Jeannet F, Witters LA, et al: Induction by glucose of genes coding for glycolytic enzymes in a pancreatic beta-cell line (INS-1). J Biol Chem 272:3091-3098, 1997
28. Abdel-Wahab YHA, O'Harte FPM, Ratcliff H, et al: Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45:1489-1496, 1996
29. Matsuoka T, Kajimoto Y, Watada H, et al: Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99:144-150, 1997
30. Kaneto H, Fujii J, Myint T, et al: Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 320:855-863, 1996
31. Donath MY, Gross DJ, Kaiser N: Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744, 1999
32. Pick A, Clark J, Kubstrup C, et al: Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364, 1998
33. Takami K, Odaka H, Tsukuda R, et al: Antidiabetic actions of a disaccharidase inhibitor, AO-128, in spontaneously diabetic (GK) rats. Jpn Pharmacol Ther 19:4457-4467, 1991
34. Ihara Y, Toyokuni S, Uchida K, et al: Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927-932, 1999